Laura Poteet
Family · Powell, TNNPI 1104577642
Payments from drug & device makers
Across 124 payments — averaging $30.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Johnson & Johnson$220
- AstraZeneca$178
- Eisai Inc.$152
- Genentech USA, Inc.$149
- Bristol Myers Squibb$128
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,48066%
- Other$1,28034%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 28 | $1,585 |
| Johnson & Johnson | 10 | $220 |
| AstraZeneca(2 entities) | 7 | $178 |
| Eisai Inc. | 7 | $152 |
| Genentech USA, Inc. | 7 | $149 |
| Bristol Myers Squibb | 6 | $128 |
| Merck | 5 | $124 |
| Sanofi | 5 | $124 |
| Pfizer | 5 | $100 |
| Incyte Corporation | 4 | $86 |
| Springworks Therapeutics, Inc. | 1 | $76 |
| Deciphera Pharmaceuticals Inc. | 3 | $73 |
| Ipsen Biopharmaceuticals, Inc | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Bayer | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Sobi, Inc | 2 | $41 |
| Array Biopharma Inc | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Karyopharm Therapeutics Inc. | 1 | $32 |
| Tersera Therapeutics LLC | 2 | $31 |
| Caris MPI, Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| AbbVie | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Servier Pharmaceuticals LLC | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Beone Medicines USA, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Exelixis Inc. | 1 | $19 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| Taiho Oncology, Inc. | 1 | $18 |
| Mirati Therapeutics, Inc. | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| GSK | 1 | $16 |
How this compares
$3,759 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exemestane | 13 | $1,167 |
| Letrozole | 23 | $425 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 15 | $330 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $241 |
| Oxycodone Hcl | 12 | $190 |
| Gabapentin | 11 | $126 |
| Folic Acid | 15 | $77 |
Paid to pharmacies, not to this prescriber.
Other family in Powell
- Amy GreenePowell$19K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.